News

Eli Lilly Stock Dives on Weight-Loss Pill Data as Earnings Beat Expectations. What to Know.
Eli Lilly stock falls after new data on its weight-loss drug Orforglipron, ahead of scheduled second-quarter earnings.
Lilly: Q2 Earnings Snapshot
Earnings, adjusted for one-time gains and costs, came to $6.31 per share. The results surpassed Wall Street expectations. The ...
The Daily Reporter13h
Eli Lilly and Co. could get $100 million in state tax credits
Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...
These Stocks Are Moving the Most Today: Fortinet, AppLovin, Eli Lilly, Airbnb, Duolingo, and More
A slew or company results were causing big market moves ahead of the opening bell Thursday, and for many, earnings-beat ...
Lilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity
Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ATTAIN-1 trial, evaluating ...
Eli Lilly Earnings, Fed Speakers, Bank of England Rate Decision: Still to Come This Week
Earnings season marches on, with Eli Lilly among the big names yet to report this week. President Trump has said he will name replacements this week for Federal Reserve governor Adriana Kugler and [Bu ...
Jim Cramer Shows Concerns That Eli Lilly “Might Be a Little Diluted”
Eli Lilly and Company (NYSE:LLY) is one of the stocks in Jim Cramer’s game plan for this week. Cramer highlighted that his ...
Hosted on MSN3h
Nasdaq, S&P 500 Futures Climb Despite Trump Tariff Rollout — Spotlight On Jobs Data, Eli Lilly, Warner Bros. Earnings
U.S. stock futures strengthened early Thursday, despite a tariff threat looming large. President Donald Trump confirmed by ...